Navigation Links
Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
Date:12/20/2007

BETHESDA, Md., Dec. 20 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBS and NWBT), Northwest Biotherapeutics ("NWBT") announced today that Lonza Group AG has withdrawn all claims of patent infringement involving NWBT's DCVax(R)-Brain product and other NWBT DCVax(R) products other than DCVax(R)-Prostate. Lonza had alleged that NWBT's DCVax(R) cancer vaccine products infringed certain gene expression technology patents held by Lonza. However, as could be seen from publicly available information sources -- available before the Lonza lawsuit was filed as well as since then -- NWBT does not use any gene modification or gene expression system in its DCVax(R) products.

Lonza filed suit against NWBT on July 27, 2007, in the U.S. District Court for the District of Delaware, alleging that all of NWBT's DCVax(R) products infringed certain gene expression patents held by Lonza. After the filing of a lawsuit, a period of up to 120 days is allowed for service of the complaint on the party sued. In this case, Lonza chose not to serve NWBT throughout the entire 120-day period. As a result, the filing of an answer and counterclaims by NWBT was delayed until this extended period had expired. During the 120-day period, NWBT provided further information to Lonza -- in addition to the already publicly available information sources -- showing that NWBT's DCVax(R) products do not use any gene expression system. When Lonza still chose not to withdraw its complaint, NWBT filed an answer and counterclaims as soon as the 120-day period expired, denying all infringement claims by Lonza, and seeking recovery for violation of the Delaware Deceptive Trade Practices Act, unfair competition, tortious interference with prospective contractual relations, and abuse of process, including, among other things, treble damages and punitive damages. Following NWBT's filing of this answer and counterclaim, Lonza agreed with NWBT to the dismissal of
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
2. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
3. Zimmer Holdings Announces Support for Elimination of Super-Majority Voting Requirements
4. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
5. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
6. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
7. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
8. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
9. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
10. Pressure BioSciences, Inc. Issued First Patent in Canada
11. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... 2015 Capillus, LLC announces plans ... network in Europe and Asia. The Miami-based medical ... Bermúdez, former Business Development Director of Svenson Group ... Mr. Bermúdez’s professional achievements include increasing the number ... also penetrating the Portuguese marketplace with centers in ...
(Date:4/16/2015)... April 16, 2015 OncoTAb, ... Charlotte (UNC Charlotte) spin-out company, announced today the ... Ph.D., M.D., as Chief Operating Officer (COO). Cooper ... experience in developing clinical diagnostic and biotechnology platforms ... disease. , Cooper’s extensive career transcends the field ...
(Date:4/16/2015)... , April 16, 2015 /CNW/ - Bioenterprise Corporation is pleased ... office in Charlottetown , PEI.  Bioenterprise ... Edward Island ADAPT Council for the commercialization of agricultural ... to working with PEI ADAPT.  They have been at ... than a decade," explains Dave Smardon , President ...
(Date:4/16/2015)... 16, 2015 Avelas Biosciences, an in ... surgeries, announced today that it has initiated a Phase ... in women with primary, non-recurrent breast cancer undergoing surgery. ... the addition of Steven Chen , M.D., as ... label, dose escalation study will enroll up to 39 ...
Breaking Biology Technology:Capillus, LLC Extends Laser Hair Therapy Products to Europe and Asia 2OncoTAb Names Dr. David L. Cooper as COO 2Bioenterprise Corporation Expands into the Maritimes 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3
... CHANDLER, Ariz., April 20, 2011 ... from the U.S.-grown guayule plant as a replacement for ... and the residual agricultural materials are utilized as a ... ecologically responsible and carbon neutral, resulting in a new ...
... LOS ANGELES, April 20, 2011 European Medical Device ... Industry ( MD+DI ), and Qmed, the ... engine, have announced the keynote and session speakers for the ... emerging innovations in materials for medical applications . ...
... 20, 2011 "We are in the midst of a ... major health issues such as cancer. It is based upon ... human tissue," said Howard Stillman, a veteran Wall Street Securities ... Health Discovery Corporation (OTC Bulletin Board: HDVY ), ...
Cached Biology Technology:Every Day is Earth Day for Yulex Corporation 2Keynote Announced for Virtual Event: Developments in Materials for Medical Applications 2Keynote Announced for Virtual Event: Developments in Materials for Medical Applications 3Keynote Announced for Virtual Event: Developments in Materials for Medical Applications 4Keynote Announced for Virtual Event: Developments in Materials for Medical Applications 5Veteran Wall Street Securities Analyst Reports on Health Discovery Corporation 2
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... of the "Global Iris Recognition Market 2015-2019" ... the Global Iris Recognition market to grow at a ... This report covers the present scenario and the ... the period 2015-2019. To calculate the market size, the ...
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs ... management company, today announced that the Company will demonstrate ... both enterprise and consumers at Connect:ID on March 23 ... HOYOS Labs will highlight the IEEE Biometric Open ... ; and enterprise access control system. BOPS was ...
(Date:3/20/2015)... OXFORD, Conn. , March 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... Wocket® smart wallet is one of the products featured ... today, March 20th at 11:00 PM EST on the ... travels to Las Vegas , site ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... teaching with a particular emphasis on radioactivity and radiation ... environmental benefits and relative safety of nuclear power generation, ... that it might then be possible to have a ... that will ultimately reduce our reliance on fossil fuels. ...
... MA Researchers at Brigham and Women,s Hospital (BWH) ... clock, regulates human platelet function and causes a peak ... in adverse cardiovascular events. These findings are published in ... "Cardiovascular disease is still the number one cause ...
... the function of a cancer gene involved in the formation ... switch and growth signals, rather than targeting the gene itself. ... strategy for treating not only myeloma but also many other ... say. Their findings are being published by the journal ...
Cached Biology News:Rebalancing the nuclear debate through education 2Body clock found to regulate platelet function 2Novel approach scores first success against elusive cancer gene 2
AC input: 50-60 Hz230 V...
AC input: 50-60 Hz 115-120 V...
... specifically for Alkaline Phosphatase conjugates. The ... for both the enzyme and the antibody ... This product has been chemically engineered to ... longer shelf life, resistance to various shipping ...
... The SDSaway reagent is a valuable tool ... The presence of SDS in biological ... tightly bound SDS-protein complex, inhibits enzymatic activity ... presents as a contaminant in mass spectrometry ...
Biology Products: